November 16, 2023
RegMed Investors (RMi) Research Note: Homology Medicines (FIXX) enters into merger agreement and financing with Q32 Bio Inc. in an all-stock transaction
November 10, 2023
RegMed Investors’ (RMi) pre-open: which way as market breadth remains a challenge?
November 9, 2023
RegMed Investors’ (RMi) pre-open: sentiment loops in and fades out
November 8, 2023
RegMed Investors’ (RMi) pre-open: momentum or resistance?
November 7, 2023
RegMed Investors’ (RMi) pre-open: negative reaction to positive actions redefines contraction
November 3, 2023
RegMed Investors (RMi) Closing Bell: are the unknowns known?
November 2, 2023
RegMed Investors (RMi) Closing Bell: sector rallies … again
October 26, 2023
RegMed Investors (RMi) Closing Bell: market dives, sector thrives
October 10, 2023
RegMed Investors (RMi) Closing Bell: Falling bond yields lifted cell and gene therapy sector equities
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.